Please login to the form below

Not currently logged in
Email:
Password:

Jeffrey Gold appointed CEO of myoscience

Previously worked as president and COO at the firm
Jeffrey Gold

Jeffrey Gold has been named as CEO of medical device company myoscience.

Gold has previously held the positions of president and chief operating officer at the company. Previously he has held posts as chief executive for Velomedix and CryoVascular Systems as well as being chief operating officer for CardioThoracic Systems.

Concerning his appointment, Gold commented: “I am very excited to assume the responsibility of guiding myoscience through its next development stage. The myoscience tea has built an extremely strong platform technology that targets two distinct markets, aesthetics and peripheral nerve pain.

“We have a strong team of dedicated professionals that will drive myoscience to greater success in the future.”

Prior to his roles at Velomedix, Gold was a venture partner for Longitude Capital where he focused on investments in medical devices.

Rich Ferrari, myoscience executive chairman, added: “Jeff is a seasoned executive with a solid record of success. The myoscience board of directors fully supports the appointment and we are excited to have Jeff accept the leadership role as CEO.”

28th November 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Australian Flu and the dilemma of naming diseases
...
Wearables and Healthcare
What place do wearables have in affecting actual patient health outcomes and can they contribute to the NHS’s sustainability agenda? Or are they just the latest fad?...
What does a future-proof rep look like?
Businesses can no longer afford to push ahead with the traditional Key Account Management model....

Infographics